INNOVIVA, INC. Net Income (Loss) Available to Common Stockholders, Basic
INNOVIVA, INC. (INVA) reported Net Income (Loss) Available to Common Stockholders, Basic of -$83.42 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-05
- INNOVIVA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$83.42M, a 230.98% decline year-over-year.
- INNOVIVA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was $186.59M.
- INNOVIVA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was $164.15M, a 707.36% increase year-over-year.
- INNOVIVA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was $89.91M, a 7312.04% increase year-over-year.
- INNOVIVA, INC. net income (loss) available to common stockholders, basic for fiscal 2025 was $271.17M, a 1059.22% increase from fiscal 2024.
- INNOVIVA, INC. net income (loss) available to common stockholders, basic for fiscal 2024 was $23.39M, a 86.98% decline from fiscal 2023.
- INNOVIVA, INC. net income (loss) available to common stockholders, basic for fiscal 2023 was $179.72M, a 15.99% decline from fiscal 2022.
- INNOVIVA, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was $213.92M, a 19.53% decline from fiscal 2021.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$83.42M 10-Q · filed 2026-08-05 | $103.17M 10-Q · filed 2026-08-05 | $267.33M derived: sum of 3 quarters · filed 2026-08-05 | $357.24M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $186.59M 10-Q · filed 2026-05-06 | $350.75M derived: sum of 2 quarters · filed 2026-05-06 | $440.66M derived: sum of 3 quarters · filed 2026-05-06 | $504.34M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $164.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $254.06M derived: sum of 2 quarters · filed 2026-02-25 | $317.75M derived: sum of 3 quarters · filed 2026-08-05 | $271.17M 10-K · filed 2026-02-25 |
| 2025-09-30 | $89.91M 10-Q · filed 2025-11-05 | $153.60M derived: sum of 2 quarters · filed 2026-08-05 | $107.01M 10-Q · filed 2025-11-05 | $127.34M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $63.69M 10-Q · filed 2026-08-05 | $17.10M 10-Q · filed 2026-08-05 | $37.44M derived: sum of 3 quarters · filed 2026-08-05 | $38.65M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$46.58M 10-Q · filed 2026-05-06 | -$26.25M derived: sum of 2 quarters · filed 2026-05-06 | -$25.04M derived: sum of 3 quarters · filed 2026-05-06 | -$59.72M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $20.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $21.55M derived: sum of 2 quarters · filed 2026-02-25 | -$13.14M derived: sum of 3 quarters · filed 2026-02-25 | $23.39M 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.21M 10-Q · filed 2025-11-05 | -$33.47M derived: sum of 2 quarters · filed 2025-11-05 | $3.06M 10-Q · filed 2025-11-05 | $64.59M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$34.69M 10-Q · filed 2025-08-06 | $1.85M 10-Q · filed 2025-08-06 | $63.38M derived: sum of 3 quarters · filed 2026-02-25 | $145.42M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $36.53M 10-Q · filed 2025-05-07 | $98.06M derived: sum of 2 quarters · filed 2026-02-25 | $180.11M derived: sum of 3 quarters · filed 2026-02-25 | $181.39M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $61.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $143.58M derived: sum of 2 quarters · filed 2026-02-25 | $144.86M derived: sum of 3 quarters · filed 2026-02-25 | $179.72M 10-K · filed 2026-02-25 |
| 2023-09-30 | $82.05M 10-Q · filed 2024-11-06 | $83.33M derived: sum of 2 quarters · filed 2024-11-06 | $118.19M 10-Q · filed 2024-11-06 | $49.88M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $1.28M 10-Q · filed 2024-07-31 | $36.15M 10-Q · filed 2024-07-31 | -$32.17M derived: sum of 3 quarters · filed 2025-02-26 | $233.35M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $34.87M 10-Q · filed 2024-05-08 | -$33.45M derived: sum of 2 quarters · filed 2025-02-26 | $232.07M derived: sum of 3 quarters · filed 2025-02-26 | $233.01M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$68.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $197.21M derived: sum of 2 quarters · filed 2025-02-26 | $198.15M derived: sum of 3 quarters · filed 2025-02-26 | $213.92M 10-K · filed 2025-02-26 |
| 2022-09-30 | $265.52M 10-Q · filed 2023-11-01 | $266.46M derived: sum of 2 quarters · filed 2023-11-01 | $282.24M 10-Q · filed 2023-11-01 | $292.58M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $939.00K 10-Q · filed 2023-08-02 | $16.71M 10-Q · filed 2023-08-02 | $27.06M derived: sum of 3 quarters · filed 2024-03-05 | $99.50M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $15.77M 10-Q · filed 2023-05-09 | $26.12M derived: sum of 2 quarters · filed 2024-03-05 | $98.56M derived: sum of 3 quarters · filed 2024-03-05 | $187.50M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $10.35M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-05 | $82.78M derived: sum of 2 quarters · filed 2024-03-05 | $171.73M derived: sum of 3 quarters · filed 2024-03-05 | $265.85M 10-K/A · filed 2024-03-05 |
| 2021-09-30 | $72.44M 10-Q · filed 2022-11-09 | $161.39M derived: sum of 2 quarters · filed 2022-11-09 | $255.51M 10-Q · filed 2022-11-09 | $309.41M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $88.95M 10-Q · filed 2022-07-27 | $183.07M 10-Q · filed 2022-07-27 | $236.97M derived: sum of 3 quarters · filed 2023-02-28 | $265.19M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $94.12M 10-Q · filed 2022-05-05 | $148.03M derived: sum of 2 quarters · filed 2023-02-28 | $176.24M derived: sum of 3 quarters · filed 2023-02-28 | $253.09M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $53.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $82.12M derived: sum of 2 quarters · filed 2023-02-28 | $158.97M derived: sum of 3 quarters · filed 2023-02-28 | $224.40M 10-K · filed 2023-02-28 |
| 2020-09-30 | $28.22M 10-Q · filed 2021-10-27 | $105.06M derived: sum of 2 quarters · filed 2021-10-27 | $170.50M 10-Q · filed 2021-10-27 | $216.45M derived: sum of 4 quarters · filed 2021-10-27 |
| 2020-06-30 | $76.84M 10-Q · filed 2021-07-29 | $142.28M 10-Q · filed 2021-07-29 | $188.23M derived: sum of 3 quarters · filed 2021-07-29 | $228.04M derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-03-31 | $65.44M 10-Q · filed 2021-04-28 | $111.39M derived: sum of 2 quarters · filed 2021-04-28 | $151.19M derived: sum of 3 quarters · filed 2021-04-28 | $188.94M derived: sum of 4 quarters · filed 2021-04-28 |
| 2019-12-31 | $45.95M 10-K · filed 2020-02-19 | $85.76M derived: sum of 2 quarters · filed 2020-10-28 | $123.50M derived: sum of 3 quarters · filed 2020-10-28 | $157.29M 10-K/A · filed 2022-03-17 |
| 2019-09-30 | $39.81M 10-Q · filed 2020-10-28 | $77.55M derived: sum of 2 quarters · filed 2020-10-28 | $111.34M 10-Q · filed 2020-10-28 | $375.10M derived: sum of 4 quarters · filed 2020-10-28 |
| 2019-06-30 | $37.74M 10-Q · filed 2020-07-29 | $71.53M 10-Q · filed 2020-07-29 | $335.29M derived: sum of 3 quarters · filed 2020-07-29 | $382.38M derived: sum of 4 quarters · filed 2020-07-29 |
| 2019-03-31 | $33.79M 10-Q · filed 2020-04-29 | $297.55M derived: sum of 2 quarters · filed 2020-04-29 | $344.64M derived: sum of 3 quarters · filed 2020-04-29 | $399.26M derived: sum of 4 quarters · filed 2020-04-29 |
| 2018-12-31 | $263.76M 10-K · filed 2020-02-19 | $310.85M derived: sum of 2 quarters · filed 2020-02-19 | $365.48M derived: sum of 3 quarters · filed 2020-02-19 | $395.06M 10-K · filed 2021-02-25 |
| 2018-09-30 | $47.09M 10-K · filed 2020-02-19 | $101.72M derived: sum of 2 quarters · filed 2020-02-19 | $131.30M 10-Q · filed 2019-10-30 | $189.68M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $54.63M 10-K · filed 2020-02-19 | $84.21M 10-Q · filed 2019-07-24 | $142.59M derived: sum of 3 quarters · filed 2020-02-19 | $166.36M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $29.58M 10-K · filed 2020-02-19 | $87.97M derived: sum of 2 quarters · filed 2020-02-19 | $111.73M derived: sum of 3 quarters · filed 2020-02-19 | $146.88M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $58.38M 10-K · filed 2019-02-19 | $82.15M derived: sum of 2 quarters · filed 2019-02-19 | $117.30M derived: sum of 3 quarters · filed 2019-02-19 | $134.14M 10-K · filed 2020-02-19 |
| 2017-09-30 | $23.77M 10-K · filed 2019-02-19 | $58.91M derived: sum of 2 quarters · filed 2019-02-19 | $75.76M 10-Q · filed 2018-10-31 | $101.64M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-06-30 | $35.15M 10-K · filed 2019-02-19 | $51.99M 10-Q · filed 2018-07-26 | $77.87M derived: sum of 3 quarters · filed 2019-02-19 | $92.91M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-03-31 | $16.84M 10-K · filed 2019-02-19 | $42.73M derived: sum of 2 quarters · filed 2019-02-19 | $57.76M derived: sum of 3 quarters · filed 2019-02-19 | $72.36M derived: sum of 4 quarters · filed 2019-02-19 |
| 2016-12-31 | $25.88M 10-K · filed 2017-02-28 | $40.92M derived: sum of 2 quarters · filed 2017-11-03 | $55.51M derived: sum of 3 quarters · filed 2017-11-03 | $59.54M 10-K · filed 2019-02-19 |
| 2016-09-30 | $15.03M 10-Q · filed 2017-11-03 | $29.63M derived: sum of 2 quarters · filed 2017-11-03 | $34.06M 10-Q · filed 2017-11-03 | $38.37M derived: sum of 4 quarters · filed 2017-11-03 |
| 2016-06-30 | $14.60M 10-Q · filed 2017-08-08 | $19.03M 10-Q · filed 2017-08-08 | $23.33M derived: sum of 3 quarters · filed 2017-08-08 | $18.75M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $4.43M 10-Q · filed 2017-05-05 | $8.74M derived: sum of 2 quarters · filed 2017-05-05 | $4.15M derived: sum of 3 quarters · filed 2017-05-05 | -$3.66M derived: sum of 4 quarters · filed 2017-05-05 |
| 2015-12-31 | $4.30M 10-K · filed 2017-02-28 | -$283.00K derived: sum of 2 quarters · filed 2017-02-28 | -$8.09M derived: sum of 3 quarters · filed 2017-02-28 | -$18.76M 10-K · filed 2018-02-23 |
| 2015-09-30 | -$4.58M 10-K · filed 2017-02-28 | -$12.39M derived: sum of 2 quarters · filed 2017-02-28 | -$23.06M 10-Q · filed 2016-11-03 | -$38.99M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | -$7.81M 10-K · filed 2017-02-28 | -$18.48M 10-Q · filed 2016-08-04 | -$34.40M derived: sum of 3 quarters · filed 2017-02-28 | -$55.67M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | -$10.67M 10-K · filed 2017-02-28 | -$26.59M derived: sum of 2 quarters · filed 2017-02-28 | -$47.86M derived: sum of 3 quarters · filed 2017-02-28 | -$111.43M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | -$15.93M 10-K · filed 2016-02-24 | -$37.20M derived: sum of 2 quarters · filed 2016-02-24 | -$100.76M derived: sum of 3 quarters · filed 2016-02-24 | -$168.46M 10-K · filed 2017-02-28 |
| 2014-09-30 | -$21.27M 10-K · filed 2016-02-24 | -$84.83M derived: sum of 2 quarters · filed 2016-02-24 | -$152.54M 10-Q · filed 2015-11-05 | -$202.47M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-30 | -$63.56M 10-K · filed 2016-02-24 | -$131.27M 10-Q · filed 2015-08-06 | -$181.20M derived: sum of 3 quarters · filed 2016-02-24 | -$228.18M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-31 | -$67.70M 10-K · filed 2016-02-24 | -$117.63M derived: sum of 2 quarters · filed 2016-02-24 | -$164.62M derived: sum of 3 quarters · filed 2016-02-24 | -$201.05M derived: sum of 4 quarters · filed 2016-02-24 |
| 2013-12-31 | -$49.93M 10-K · filed 2015-02-27 | -$96.91M derived: sum of 2 quarters · filed 2015-02-27 | -$133.34M derived: sum of 3 quarters · filed 2015-02-27 | -$170.70M 10-K · filed 2016-02-24 |
| 2013-09-30 | -$46.98M 10-K · filed 2015-02-27 | -$83.41M derived: sum of 2 quarters · filed 2015-02-27 | -$120.77M 10-Q · filed 2014-11-04 | -$152.10M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | -$36.43M 10-K · filed 2015-02-27 | -$73.79M 10-Q · filed 2014-08-07 | -$105.11M derived: sum of 3 quarters · filed 2015-02-27 | -$139.81M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | -$37.36M 10-K · filed 2015-02-27 | -$68.68M derived: sum of 2 quarters · filed 2015-02-27 | -$103.38M derived: sum of 3 quarters · filed 2015-02-27 | -$140.50M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | -$31.32M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$66.02M derived: sum of 2 quarters · filed 2015-02-27 | -$103.14M derived: sum of 3 quarters · filed 2015-02-27 | -$18.54M 10-K · filed 2015-02-27 |
| 2012-09-30 | -$34.69M 10-Q · filed 2013-11-01 | -$71.81M derived: sum of 2 quarters · filed 2013-11-01 | $12.78M 10-Q · filed 2013-11-01 | -$24.23M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | -$37.12M 10-Q · filed 2013-08-01 | $47.47M 10-Q · filed 2013-08-01 | $10.47M derived: sum of 3 quarters · filed 2014-03-03 | -$20.16M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $84.59M 10-Q · filed 2013-05-01 | $47.59M derived: sum of 2 quarters · filed 2014-03-03 | $16.96M derived: sum of 3 quarters · filed 2014-03-03 | -$8.08M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | -$37.01M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$67.63M derived: sum of 2 quarters · filed 2014-03-03 | -$92.68M derived: sum of 3 quarters · filed 2014-03-03 | -$115.34M 10-K · filed 2014-03-03 |
| 2011-09-30 | -$30.63M 10-Q · filed 2012-10-31 | -$55.67M derived: sum of 2 quarters · filed 2012-10-31 | -$78.34M 10-Q · filed 2012-10-31 | |
| 2011-06-30 | -$25.05M 10-Q · filed 2012-08-01 | -$47.71M 10-Q · filed 2012-08-01 | ||
| 2010-12-31 | -$19.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$40.52M derived: sum of 2 quarters · filed 2013-02-26 | -$83.86M 10-K · filed 2013-02-26 | |
| 2010-09-30 | -$21.22M 10-Q · filed 2011-11-02 | -$64.56M 10-Q · filed 2011-11-02 | ||
| 2009-12-31 | -$85.30M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |